2020
DOI: 10.1097/meg.0000000000001705
|View full text |Cite
|
Sign up to set email alerts
|

The combination of balloon-assisted antegrade transvenous obliteration and transjugular intrahepatic portosystemic shunt for the management of cardiofundal varices hemorrhage

Abstract: This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CC-BY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.Objectives: In this study, we propose a modified balloon-occluded retrograde transvenous obliteration (BRTO) strategy -balloon-assisted antegrade transvenous obliteration (BAATO), an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
10
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 33 publications
0
10
0
Order By: Relevance
“…[57][58][59][60][61][62][63][64] Nevertheless, balloon-retrograde transvenous obliteration requires the presence of a spontaneous portosystemic shunt (eg, gastro Q31 or splenorenal shunt) and may be associated with increased ascites and bleeding from esophageal varices. TIPS combined with variceal obliteration appears to be associated with a potential decrease in rebleeding rates (0%-15%), [65][66][67] particularly when the pretreatment PSG is less than 12 mm Hg. In addition to the earlierdescribed considerations, the most appropriate management for bleeding from GV will depend on the vascular anatomy of the portal venous system in addition to center and surgeon expertise.…”
Section: Specific Considerations For Transjugular Intrahepatic Portosystemic Shunt By Indicationmentioning
confidence: 99%
See 2 more Smart Citations
“…[57][58][59][60][61][62][63][64] Nevertheless, balloon-retrograde transvenous obliteration requires the presence of a spontaneous portosystemic shunt (eg, gastro Q31 or splenorenal shunt) and may be associated with increased ascites and bleeding from esophageal varices. TIPS combined with variceal obliteration appears to be associated with a potential decrease in rebleeding rates (0%-15%), [65][66][67] particularly when the pretreatment PSG is less than 12 mm Hg. In addition to the earlierdescribed considerations, the most appropriate management for bleeding from GV will depend on the vascular anatomy of the portal venous system in addition to center and surgeon expertise.…”
Section: Specific Considerations For Transjugular Intrahepatic Portosystemic Shunt By Indicationmentioning
confidence: 99%
“…The presence of a patent TIPS in patients undergoing LT is unlikely to negatively impact surgical outcomes, although it may increase surgical complexity. [65][66][67][68] During LT, the presence of TIPS may cause hyperdynamic circulation and increased portal flow, 67,69 but does not impact blood transfusion requirements, surgical time, or hospital length of stay. [65][66][67][68] Surgical factors are more favorable with TIPS compared with pretransplant surgical shunts.…”
Section: General Considerations For Transjugular Intrahepatic Portosystemic Shuntmentioning
confidence: 99%
See 1 more Smart Citation
“…40 Balloon-assisted antegrade transvenous obliteration (BAATO) combined with TIPS has also been shown to be safe and effective in management of gastric varices in a recent study. 41…”
Section: J O U R N a L P R E -P R O O Fmentioning
confidence: 99%
“…Saad et al [ 67 ] therefore proposed use of BATO via the TIPS route, combined TIPS and BRTO, or combined BATO and BRTO, depending on the clinical situation. A recent study[ 68 ] has proposed a modified method, balloon-assisted antegrade transvenous obliteration (BAATO), in which balloon occlusion of the GRS is performed in retrograde fashion followed by antegrade trans-TIPS catheter injection of CA rather than sclerosant. The distribution of CA in GVs can be controlled by modifying blood flow velocity via balloon size adjustment.…”
Section: Combined Treatmentmentioning
confidence: 99%